1887

Abstract

This article reports long-term infection and treatment failure in 18 symptomatic individuals infected with spp Patients were initially treated with either metronidazole, iodoquinol or triple combination therapy consisting of nitazoxanide, furazolidone and secnidazole. Following treatment, resolution of clinical symptoms did not occur and follow-up testing revealed ongoing infection with the same subtype. Patients then underwent secondary treatment with a variety of antimicrobial agents but remained symptomatic with spp. still present in faeces. Sequencing of the SSU rDNA was completed on all isolates and four subtypes were identified in this group: ST1, ST3, ST4 and ST5. This study highlights the lack of efficacy of several commonly used antimicrobial regimens in the treatment of and the chronic nature of some infections. It also demonstrates the need for further research into treatment options for infection.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.065508-0
2014-02-01
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/2/252.html?itemId=/content/journal/jmm/10.1099/jmm.0.065508-0&mimeType=html&fmt=ahah

References

  1. Andiran N. , Acikgoz Z. C. , Turkay S. , Andiran F. . ( 2006; ). Blastocystis hominis – an emerging and imitating cause of acute abdomen in children. . J Pediatr Surg 41:, 1489–1491. [CrossRef] [PubMed]
    [Google Scholar]
  2. Armentia A. , Méndez J. , Gómez A. , Sanchís E. , Fernández A. , de la Fuente R. , Sánchez P. . ( 1993; ). Urticaria by Blastocystis hominis. Successful treatment with paromomycin. . Allergol Immunopathol (Madr) 21:, 149–151.[PubMed]
    [Google Scholar]
  3. Boorom K. F. , Smith H. , Nimri L. , Viscogliosi E. , Spanakos G. , Parkar U. , Li L.-H. , Zhou X.-N. , Ok Ã. Z. . & other authors ( 2008; ). Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. . Parasite Vectors 1:, 40. [CrossRef] [PubMed]
    [Google Scholar]
  4. Cimerman S. , Ladeira M. C. , Iuliano W. A. . ( 2003; ). [Blastocystosis: nitazoxanide as a new therapeutic option]. . Rev Soc Bras Med Trop 36:, 415–417 (in Portuguese).[PubMed] [CrossRef]
    [Google Scholar]
  5. Dinleyici E. C. , Eren M. , Dogan N. , Reyhanioglu S. , Yargic Z. A. , Vandenplas Y. . ( 2011; ). Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. . Parasitol Res 108:, 541–545. [CrossRef] [PubMed]
    [Google Scholar]
  6. Forsell J. , Granlund M. , Stensvold C. R. , Clark G. C. , Evengård B. . ( 2012; ). Subtype analysis of Blastocystis isolates in Swedish patients. . Eur J Clin Microbiol Infect Dis 31:, 1689–1696. [CrossRef] [PubMed]
    [Google Scholar]
  7. Fotedar R. , Stark D. , Beebe N. , Marriott D. , Ellis J. , Harkness J. . ( 2007; ). PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia. . J Clin Microbiol 45:, 1035–1037. [CrossRef] [PubMed]
    [Google Scholar]
  8. Hussein E. M. , Hussein A. M. , Eida M. M. , Atwa M. M. . ( 2008; ). Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. . Parasitol Res 102:, 853–860. [CrossRef] [PubMed]
    [Google Scholar]
  9. Jantermtor S. , Pinlaor P. , Sawadpanich K. , Pinlaor S. , Sangka A. , Wilailuckana C. , Wongsena W. , Yoshikawa H. . ( 2013; ). Subtype identification of Blastocystis spp. isolated from patients in a major hospital in northeastern Thailand. . Parasitol Res 112:, 1781–1786. [CrossRef] [PubMed]
    [Google Scholar]
  10. Jones M. S. , Whipps C. M. , Ganac R. D. , Hudson N. R. , Boorom K. . ( 2009; ). Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. . Parasitol Res 104:, 341–345. [CrossRef] [PubMed]
    [Google Scholar]
  11. Kick G. , Rueff F. , Przybilla B. . ( 2002; ). Palmoplantar pruritus subsiding after Blastocystis hominis eradication. . Acta Derm Venereol 82:, 60. [CrossRef] [PubMed]
    [Google Scholar]
  12. Leelayoova S. , Rangsin R. , Taamasri P. , Naaglor T. , Thathaisong U. , Mungthin M. . ( 2004; ). Evidence of waterborne transmission of Blastocystis hominis . . Am J Trop Med Hyg 70:, 658–662.[PubMed]
    [Google Scholar]
  13. Markell E. K. , Udkow M. P. . ( 1986; ). Blastocystis hominis: pathogen or fellow traveler. ? Am J Trop Med Hyg 35:, 1023–1026.[PubMed]
    [Google Scholar]
  14. Meenagh A. , Williams F. , Ross O. A. , Patterson C. , Gorodezky C. , Hammond M. , Leheny W. A. , Middleton D. . ( 2002; ). Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. . Hum Immunol 63:, 1055–1061. [CrossRef] [PubMed]
    [Google Scholar]
  15. Meloni D. , Sanciu G. , Poirier P. , El Alaoui H. , Chabé M. , Delhaes L. , Dei-Cas E. , Delbac F. , Luigi Fiori P. . & other authors ( 2011; ). Molecular subtyping of Blastocystis spp. isolates from symptomatic patients in Italy. . Parasitol Res 109:, 613–619. [CrossRef] [PubMed]
    [Google Scholar]
  16. Mirza H. , Teo J. D. , Upcroft J. , Tan K. S. . ( 2011; ). A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. . Antimicrob Agents Chemother 55:, 637–648. [CrossRef] [PubMed]
    [Google Scholar]
  17. Moghaddam D. D. , Ghadirian E. , Azami M. . ( 2005; ). Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. . Parasitol Res 96:, 273–275. [CrossRef] [PubMed]
    [Google Scholar]
  18. Nagel R. , Cuttell L. , Stensvold C. R. , Mills P. C. , Bielefeldt-Ohmann H. , Traub R. J. . ( 2012; ). Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy. . Intern Med J 42:, 1187–1195. [CrossRef] [PubMed]
    [Google Scholar]
  19. Nigro L. , Larocca L. , Massarelli L. , Patamia I. , Minniti S. , Palermo F. , Cacopardo B. . ( 2003; ). A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. . J Travel Med 10:, 128–130. [CrossRef] [PubMed]
    [Google Scholar]
  20. Ok U. Z. , Girginkardeşler N. , Balcioğlu C. , Ertan P. , Pirildar T. , Kilimcioğlu A. A. . ( 1999; ). Effect of trimethoprim–sulfamethoxazole in Blastocystis hominis infection. . Am J Gastroenterol 94:, 3245–3247. [CrossRef] [PubMed]
    [Google Scholar]
  21. Olivo-Diaz A. , Romero-Valdovinos M. , Gudiño-Ramirez A. , Reyes-Gordillo J. , Jimenez-Gonzalez D. E. , Ramirez-Miranda M. E. , Martinez-Flores W. A. , Martinez-Hernandez F. , Flisser A. , Maravilla P. . ( 2012; ). Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis . . Parasitol Res 111:, 487–491. [CrossRef] [PubMed]
    [Google Scholar]
  22. Özyurt M. , Kurt O. , Mølbak K. , Nielsen H. V. , Haznedaroglu T. , Stensvold C. R. . ( 2008; ). Molecular epidemiology of Blastocystis infections in Turkey. . Parasitol Int 57:, 300–306. [CrossRef] [PubMed]
    [Google Scholar]
  23. Parkar U. , Traub R. J. , Vitali S. , Elliot A. , Levecke B. , Robertson I. , Geurden T. , Steele J. , Drake B. , Thompson R. C. . ( 2010; ). Molecular characterization of Blastocystis isolates from zoo animals and their animal-keepers. . Vet Parasitol 169:, 8–17. [CrossRef] [PubMed]
    [Google Scholar]
  24. Pasqui A. L. , Savini E. , Saletti M. , Guzzo C. , Puccetti L. , Auteri A. . ( 2004; ). Chronic urticaria and Blastocystis hominis infection: a case report. . Eur Rev Med Pharmacol Sci 8:, 117–120.[PubMed]
    [Google Scholar]
  25. Pipatsatitpong D. , Rangsin R. , Leelayoova S. , Naaglor T. , Mungthin M. . ( 2012; ). Incidence and risk factors of Blastocystis infection in an orphanage in Bangkok, Thailand. . Parasite Vectors 5:, 37. [CrossRef] [PubMed]
    [Google Scholar]
  26. Roberts T. , Stark D. , Harkness J. , Ellis J. . ( 2013; ). Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis . . Eur J Clin Microbiol Infect Dis 32:, 335–343. [CrossRef] [PubMed]
    [Google Scholar]
  27. Romero Cabello R. , Guerrero L. R. , Muñóz García M. R. , Geyne Cruz A. . ( 1997; ). Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. . Trans R Soc Trop Med Hyg 91:, 701–703. [CrossRef] [PubMed]
    [Google Scholar]
  28. Rossignol J. F. , Kabil S. M. , Said M. , Samir H. , Younis A. M. . ( 2005; ). Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis . . Clin Gastroenterol Hepatol 3:, 987–991. [CrossRef] [PubMed]
    [Google Scholar]
  29. Stark D. , van Hal S. , Marriott D. , Ellis J. , Harkness J. . ( 2007; ). Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. . Int J Parasitol 37:, 11–20. [CrossRef] [PubMed]
    [Google Scholar]
  30. Stark D. , Barratt J. , Roberts T. , Marriott D. , Harkness J. , Ellis J. . ( 2010; ). Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples. . Eur J Clin Microbiol Infect Dis 29:, 411–416. [CrossRef] [PubMed]
    [Google Scholar]
  31. Stensvold C. R. , Arendrup M. C. , Jespersgaard C. , Mølbak K. , Nielsen H. V. . ( 2007; ). Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. . Diagn Microbiol Infect Dis 59:, 303–307. [CrossRef] [PubMed]
    [Google Scholar]
  32. Stensvold C. R. , Arendrup M. C. , Nielsen H. V. , Bada A. , Thorsen S. . ( 2008; ). Symptomatic infection with Blastocystis spp. subtype 8 successfully treated with trimethoprim–sulfamethoxazole. . Ann Trop Med Parasitol 102:, 271–274. [CrossRef] [PubMed]
    [Google Scholar]
  33. Stensvold C. R. , Lewis H. C. , Hammerum A. M. , Porsbo L. J. , Nielsen S. S. , Olsen K. E. , Arendrup M. C. , Nielsen H. V. , Mølbak K. . ( 2009; ). Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. . Epidemiol Infect 137:, 1655–1663. [CrossRef] [PubMed]
    [Google Scholar]
  34. Stensvold C. R. , Smith H. V. , Nagel R. , Olsen K. E. , Traub R. J. . ( 2010; ). Eradication of Blastocystis carriage with antimicrobials: reality or delusion. ? J Clin Gastroenterol 44:, 85–90. [CrossRef] [PubMed]
    [Google Scholar]
  35. Tan K. S. . ( 2008; ). New insights on classification, identification, and clinical relevance of Blastocystis spp. . Clin Microbiol Rev 21:, 639–665. [CrossRef] [PubMed]
    [Google Scholar]
  36. Tan K. S. , Singh M. , Yap E. H. . ( 2002; ). Recent advances in Blastocystis hominis research: hot spots in terra incognita. . Int J Parasitol 32:, 789–804. [CrossRef] [PubMed]
    [Google Scholar]
  37. Valsecchi R. , Leghissa P. , Greco V. . ( 2004; ). Cutaneous lesions in Blastocystis hominis infection. . Acta Derm Venereol 84:, 322–323. [CrossRef] [PubMed]
    [Google Scholar]
  38. van Hellemond J. J. , Molhoek N. , Koelewijn R. , Wismans P. J. , van Genderen P. J. . ( 2013; ). Is paromomycin the drug of choice for eradication of Blastocystis in adults. ? J Infect Chemother 19:, 545–548. [CrossRef] [PubMed]
    [Google Scholar]
  39. Vogelberg C. , Stensvold C. R. , Monecke S. , Ditzen A. , Stopsack K. , Heinrich-Gräfe U. , Pöhlmann C. . ( 2010; ). Blastocystis spp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms. . Parasitol Int 59:, 469–471. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.065508-0
Loading
/content/journal/jmm/10.1099/jmm.0.065508-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error